Exane Derivatives’s Agilent Technologies A Stock Holding History

Exane Derivatives’s Portfolio A Stock Details A Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$3.8K	Sell	32 -879	-96%	-$108K	﹤0.01%	402
2022 Q1	$121K	Sell	911 -1,228	-57%	-$169K	0.03%	442
2021 Q4	$341K	Buy	2,139 +664	+45%	+$103K	0.08%	238
2021 Q3	$232K	Sell	1,475 -2,571	-64%	-$416K	0.06%	356
2021 Q2	$604K	Buy	4,046 +1,795	+80%	+$245K	0.14%	148
2021 Q1	$286K	Sell	2,251 -942	-30%	-$116K	0.08%	228
2020 Q4	$378K	Buy	+3,193	New	+$353K	0.11%	217

Other funds holding A

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Exane Derivatives's A Position: Q2 2022 in Review

Exane Derivatives reduced its Agilent Technologies (A) stake by 96% in Q2 2022, selling an estimated $108K and leaving 32 shares worth $3.8K. The position accounts for ﹤0.01% of the portfolio, ranked #402.

Exane Derivatives first reported a position in A in Q4 2020 and has held it in 7 quarters since. The position peaked at $604K in Q2 2021. 885 funds tracked by Wall St. Rank hold A as of Q2 2022.

Exane Derivatives held 32 shares of Agilent Technologies worth $3.8K as of Q2 2022.
Exane Derivatives sold 879 Agilent Technologies shares in Q2 2022, an estimated $108K.
Agilent Technologies made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #402 holding.
Exane Derivatives first reported a position in Agilent Technologies in Q4 2020 and has held it in 7 quarters since.
Exane Derivatives's Agilent Technologies position peaked at $604K in Q2 2021.
885 funds tracked by Wall St. Rank held Agilent Technologies as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.